A carregar...

Left Behind? Drug Discovery in Extensive Stage Small Cell Lung Cancer

Systemic therapy and subsequent survival for patients with extensive stage small cell lung cancer (SCLC) are poor and have remained unchanged in the last quarter century. To improve outcomes in these patients, a new drug development paradigm must be adopted that moves away from empiricism and instea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Riess, Jonathan W., Lara, Primo N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184801/
https://ncbi.nlm.nih.gov/pubmed/24529447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2013.12.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!